The goal of the clinical trial is to compare laser therapy with ultrasonic therapy in patients with inflammation in the tissue surrounding single implants (peri-implant mucositis). The outcomes are bleeding on probing (BOP), pocket depth, suppuration, recession of the peri-implant mucosal margin, the treatment time and changes in bone levels before and after treatment in the test, and control group respectively. The quality of life will be measured from a standardized protocol. The hypothesis is that treatment with laser therapy in patients with peri-implant mucositis will show less inflammation with less bleeding and a better pocket closure compared to the treatment with the ultrasound.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bleeding on probing (BOP)
Timeframe: Baseline
Bleeding on probing (BOP)
Timeframe: 1 month
Bleeding on probing (BOP)
Timeframe: 3 months
Bleeding on probing (BOP)
Timeframe: 6 months
Probing pocket depth (PPD)
Timeframe: Baseline
Probing pocket depth (PPD)
Timeframe: 1 month
Probing pocket depth (PPD)
Timeframe: 3 months
Probing pocket depth (PPD)
Timeframe: 6 months
Pus
Timeframe: Baseline
Pus
Timeframe: 1 month
Pus
Timeframe: 3 months
Pus
Timeframe: 6 months